8-K filing — Skye Bioscience, Inc. (SKYE)
Filed: 2026-11-12 AccNo: 0001628280-26-073120 Size: 148 KB Item 8.01: Other Events
Filings · News reference
Entry into a Material Definitive Agreement. As previously disclosed on the Current Report on Form 8-K filed by Skye Bioscience, Inc., a Nevada corporation (the "Company"), with the U.S. Securities and Exchange
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-11-12 AccNo: 0001628280-26-073120 Size: 148 KB Item 8.01: Other Events
Gainers Co-Diagnostics (NASDAQ:CODX) stock moved upwards by 22.4% to $0.39 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. As per the press release, Q3 earnings came out
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001516551/000162828026061558/skye-20260908.htm
Skye Bioscience shares rise 6% after hours on a $22M equity purchase agreement and warrant issuance.
Filed: 2026-08-20 AccNo: 0001628280-26-058120 Size: 147 KB Item 3.03: Material Modifications to Rights of Security Holders